Published in Biostatistics on June 06, 2014
A two stage design for the study of the relationship between a rare exposure and a rare disease. Am J Epidemiol (1982) 4.23
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer (2009) 3.33
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine (2008) 3.17
Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev (2010) 1.85
Using the Peters--Belson method to measure health care disparities from complex survey data. Stat Med (2005) 1.17
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. Sex Transm Dis (2010) 1.02
Piecewise exponential survival times and analysis of case-cohort data. Stat Med (2012) 0.92
Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure. Sex Transm Dis (2011) 0.91
Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. BMC Infect Dis (2014) 0.87